Figure 1From: Using fractional exhaled nitric oxide (FeNO) to diagnose steroid-responsive disease and guide asthma management in routine careAlgorithm by showing how FeNO was used in 678 patients from the OPCRD. Patients were aged ≥4 years with at least one year’s continuous patient records prior to their first FeNO reading.Back to article page